17-beta HSD1 and STS inhibitors

Substituted steroid compounds which represent selective inhibitors of 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1) and, in addition, which may represent inhibitors of the steroid sulfatase, salts thereof, pharmaceutical preparations containing these compounds, and a process for the prepa...

Full description

Saved in:
Bibliographic Details
Main Authors MESSINGER JOSEF, THOLE HEINRICH-HUBERT, KOSKIMIES PASI, HUSEN BETTINA, WESKE MICHAEL, PIRKKALA LILA
Format Patent
LanguageEnglish
Published 07.05.2013
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
STEROIDS
Online AccessGet full text

Cover

More Information
Summary:Substituted steroid compounds which represent selective inhibitors of 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1) and, in addition, which may represent inhibitors of the steroid sulfatase, salts thereof, pharmaceutical preparations containing these compounds, and a process for the preparation of these compounds. Also disclosed is a therapeutic method of using such substituted steroid compounds, particularly in the treatment, inhibition, prophylaxis or prevention of steroid hormone dependent diseases or disorders, such as steroid hormone dependent diseases or disorders requiring the inhibition of 17beta-hydroxysteroid dehydrogenase type I and/or steroid sulfatase enzymes and/or requiring lowering of the endogenous 17beta-estradiol concentration.
Bibliography:Application Number: US20100892351